Enzymotec Ltd. Announces Investigator Initiated Clinical Trial of Vayarin(R) in Managing ADHD in Children With Epilepsy
July 07, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 7, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enyzmotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based...
Enzymotec Ltd. Announces Annual General Meeting of Shareholders
June 11, 2015 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, June 11, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), today announced that it will hold an Annual General Meeting of Shareholders on Wednesday, July...
Enzymotec Ltd. to Participate in the Jefferies 2015 Global Healthcare Conference
May 20, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, May 20, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients,...
Enzymotec Ltd. Reports First Quarter 2015 Unaudited Financial Results
May 07, 2015 07:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, May 7, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported financial...
Enzymotec Ltd. Announces Positive Results Comparing Vayarol(R) to Ethyl Esters of Omega-3
April 30, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, April 30, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid based...
Enzymotec to Report First Quarter 2015 Financial Results
April 23, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, April 23, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
Enzymotec Ltd. Reports a Decision of the U.S. Patent and Trademark Office
March 24, 2015 09:23 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, March 24, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
Enzymotec Ltd. Granted New Patents in the United States and Australia Relevant to Phospholipid-Based Products
March 13, 2015 09:47 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, March 13, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
Enzymotec Ltd. Reports Fourth Quarter and Full Year 2014 Unaudited Financial Results
February 18, 2015 07:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today...
Enzymotec Ltd. Announces the Appointment of Holger Liepmann to Its Board of Directors
February 13, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced...